AN1 — Anagenics Balance Sheet

0.000.00%

Last trade - 00:00

Consumer DefensivesHighly SpeculativeMicro Cap

Annual balance sheet for Anagenics, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

	C2020 June 30th	2021 June 30th	2022 June 30th	2023 June 30th	2024 June 30th
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	6.97	6.73	3.28	2.57	1.62
Net Total Accounts Receivable
Net Total Receivables	1.87	1.8	0.921	1.09	0.651
Total Inventory
Total Other Current Assets
Total Current Assets	11.6	11.3	8.77	6.25	3.83
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1.5	0.58	0.691	0.836	0.412
Net Goodwill
Net Intangible Assets
Long Term Notes Receivable
Total Assets	14.9	13.3	12.9	11.1	6.19
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	3.64	1.92	3.66	1.71	3.17
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	5.08	2.86	4.64	2.22	3.48
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	9.81	10.4	8.29	8.9	2.71
Total Liabilities & Shareholders' Equity	14.9	13.3	12.9	11.1	6.19
Total Common Shares Outstanding